Dynamics of malaria drug resistance patterns in the amazon basin region following changes in peruvian national treatment policy for uncomplicated malaria

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 2042-2051

  Bacon, David J ^a,f   McCollum, Andrea M ^b,c,e   Griffing, Sean M ^b,e   Salas, Carola ^a   Soberon, Valeria ^a   Santolalla, Meddly ^a   Haley, Ryan ^a   Tsukayama, Pablo ^a   Lucas, Carmen ^a   Escalante, Ananias A ^d   Udhayakumar, Venkatachalam ^c,e  

^a California   (Peru)

^b EMORY UNIVERSITY   (United States)

^c ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^f Laboratory Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; MEFLOQUINE; MICROSATELLITE DNA; MOLECULAR MARKER; MULTIDRUG RESISTANCE PROTEIN; PROTOZOAL DNA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CHLOROQUINE RESISTANCE TRANSPORTER GENE; CONTROLLED STUDY; DIHYDROFOLATE REDUCTASE GENE; DIHYDROPTEROATE SYNTHASE GENE; DISEASE SEVERITY; DRUG SENSITIVITY; GENE; GENE DELETION; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; MALARIA FALCIPARUM; MICROSATELLITE MARKER; MULTIDRUG RESISTANCE GENE 1; NONHUMAN; PERU; PLASMODIUM FALCIPARUM; POINT MUTATION; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE GENE;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; GENOTYPE; HAPLOTYPES; HEALTH POLICY; HUMANS; MALARIA, FALCIPARUM; MICROSATELLITE REPEATS; MUTATION; PARASITIC SENSITIVITY TESTS; PERU; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 66149092248     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01677-08     Document Type: Article

References (35)

1. Anderson, T. J. C., and C. Roper. 2005. The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop. 94:269-280. (Pubitemid 40720332)
2. Aramburú Guarda, J., C. Ramal Asayag, and R. Witzig. 1999. Malaria reemergence in the Peruvian Amazon region. Emerg. Infect. Dis. 5:209-215. (Pubitemid 29200618)
3. Bacon, D. J., C. Latour, C. Lucas, O. Colina, P. Ringwald, and S. Picot. 2007. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob. Agents Chemother. 51:1172-1178. (Pubitemid 46586790)
4. Cortese, J. F., A. Caraballo, C. E. Contreras, and C. V. Plowe. 2002. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J. Infect. Dis. 186:999-1006.
5. 2+-ATPase orthologue of Plasmodium falciparum (PfATP6). Infect. Genet. Evol. 8:340-345.
6. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
7. Gregson, A., and C. V. Plowe. 2005. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol. Rev. 57:117-145. (Pubitemid 40283971)
8. Huaman, M. C., N. Roncal, S. Nakazawa, T. T. Long, L. Gerena, C. Garcia, L. Solari, A. J. Magill, and H. Kanbara. 2004. Polymorphism of the Plasmodium falciparum multidrug resistance and chloroquine resistance transporter genes and in vitro susceptibility to aminoquinolines in isolates from the Peruvian Amazon. Am. J. Trop. Med. Hyg. 70:461-466.
9. Jambou, R., E. Legrand, M. Niang, N. Khim, P. Lim, B. Volney, M. T. Ekala, C. Bouchier, P. Esterre, T. Fandeur, and O. Mercereau-Puijalon. 2005. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366:1960-1963.
10. Khim, N., C. Bouchier, M. T. Ekala, S. Incardona, P. Lim, E. Legrand, R. Jambou, S. Doung, O. M. Puijalon, and T. Fandeur. 2005. Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. Antimicrob. Agents Chemother. 49:3147-3152.
11. Kublin, J. G., R. S. Witzig, A. H. Shankar, J. Q. Zurita, R. H. Gilman, J. A. Guarda, J. F. Cortese, and C. V. Plowe. 1998. Molecular assays for surveillance of antifolate-resistant malaria. Lancet 351:1629-1630. (Pubitemid 28252181)
12. Laufer, M. K., P. C. Thesing, N. D. Eddington, R. Masonga, F. K. Dzinjalamala, S. L. Takala, T. E. Taylor, and C. V. Plowe. 2006. Return of chloroquine antimalarial efficacy in Malawi. N. Engl. J. Med. 355:1959-1966.
13. Magill, A. J., J. Zegarra, C. Garcia, W. Marquiño, and T. K. Ruebush II. 2004. Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru. Rev. Soc Bras Med. Trop. 37:279-281.
14. Marquiño, W., M. Huilca, C. Calampa, E. Falconi, C. Cabezas, R. Naupay, T. K. Ruebush II, J. R. MacArthur, L. M. Barat, F. E. Oblitas, M. Arrunategui, G. Garavito, M. L. Chafloque, B. Pardave, S. Gutierrez, N. Arrospide, and C. Carrillo. 2003. Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru. Am. J. Trop. Med. Hyg. 68:608-612.
15. Marquiño, W., J. R. MacArthur, L. M. Barat, F. E. Oblitas, M. Arrunategui, G. Garavito, M. L. Chafloque, B. Pardave, S. Gutierrez, N. Arrospide, C. Carrillo, C. Cabezas, and T. K. Ruebush II. 2003. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru. Am. J. Trop. Med. Hyg. 68:120-123.
16. McCollum, A. M., K. Mueller, L. Villegas, V. Udhayakumar, and A. A. Escalante. 2007. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrob. Agents Chemother. 51:2085-2091.
17. Mehlotra, R. K., H. Fujioka, P. D. Roepe, O. Janneh, L. M. Ursos, V. Jacobs-Lorena, D. T. McNamara, M. J. Bockarie, J. W. Kazura, D. E. Kyle, D. A. Fidock, and P. A. Zimmerman. 2001. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with Pfcrt polymorphism in Papua New Guinea and South America. Proc. Natl. Acad. Sci. USA 98:12689-12694.
18. Nair, S., D. Nash, D. Sudimack, A. Jaidee, M. Barends, A. C. Uhlemann, S. Krishna, F. Nosten, and T. J. Anderson. 2007. Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. Mol. Biol. Evol. 24:562-573. (Pubitemid 46204388)
19. Nash, D., S. Nair, M. Mayxay, P. N. Newton, J. P. Guthmann, F. Nosten, and T. J. Anderson. 2005. Selection strength and hitchhiking around two antimalarial resistance genes. Proc. Biol. Sci. 272:1153-1161. (Pubitemid 41020275)
20. Pillai, D. R., G. Hijar, Y. Montoya, W. Marouino, T. K. Ruebush II, C. Wongsrichanalai, and K. C. Kain. 2003. Lack of prediction of mefloquine and mefloquine-artesunate treatment outcome by mutations in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene for P. falciparum malaria in Peru. Am. J. Trop. Med. Hyg. 68:107-110. (Pubitemid 38234857)
21. Plowe, C. V., J. F. Cortese, A. Djimde, O. C. Nwanyanwu, W. M. Watkins, P. A. Winstanley, J. G. Estrada-Franco, R. E. Mollinedo, J. C. Avila, J. L. Cespedes, D. Carter, and O. K. Doumbo. 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J. Infect. Dis. 176:1590-1596.
22. Plowe, C. V., A. Djimde, M. Bouare, O. Doumbo, and T. E. Wellems. 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am. J. Trop. Med. Hyg. 52:565-568.
23. Price, R. N., A.-C. Uhlemann, A. Brockman, R. McGready, E. Ashley, L. Phaipun, R. Patel, K. Laing, S. Looareesuwan, N. J. White, F. Nosten, and S. Krishna. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447.
24. Roper, C., R. Pearce, B. Bredenkamp, J. Gumede, C. Drakeley, F. Mosha, D. Chandramohan, and B. Sharp. 2003. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 361:1174-1181. (Pubitemid 36398386)
25. Roper, C., R. Pearce, S. Nair, B. Sharp, F. Nosten, and T. Anderson. 2004. Intercontinental spread of pyrimethamine-resistant malaria. Science 305:1124. (Pubitemid 39100317)
26. Roper, M. H., R. S. Torres, C. G. Goicochea, E. M. Andersen, J. S. Guarda, C. Calampa, A. W. Hightower, and A. J. Magill. 2000. The epidemiology of malaria in an epidemic area of the Peruvian Amazon. Am. J. Trop. Med. Hyg. 62:247-256. (Pubitemid 30257585)
27. Ruebush, T. K., II, W. Marquiño, J. Zegarra, R. Villaroel, J. C. Avila, C. Díaz, and E. Beltrán. 2003. Practical aspects of in vivo antimalarial drug efficacy testing in the Americas. Am. J. Trop. Med. Hyg. 68:391-397. (Pubitemid 38230636)
28. 27a.Tanabe, K., N. Sakihama, T. Hattori, L. Ranford-Cartwright, I. Goldman, A. A. Escalante, and A. A. Lal. 2004. Genetic distance in housekeeping genes between Plasmodium falciparum and Plasmodium reichenowi and within P. falciparum. J. Mol. Evol. 59:687-694.
29. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882. (Pubitemid 28022245)
30. Vasconcelos, K. F., C. V. Plowe, C. J. Fontes, D. Kyle, D. F. Wirth, L. H. Pereira da Silva, and M. G. Zalis. 2000. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil. Mem. Inst. Oswaldo Cruz 95:721-728.
31. Vieira, P. P., M. U. Ferreira, M. G. Alecrim, W. D. Alecrim, L. H. da Silva, M. M. Sihuincha, D. A. Joy, J. Mu, X. Z. Su, and M. G. Zalis. 2004. Pfcrt polymorphism and the spread of chloroquine resistance in Plasmodium falciparum populations across the Amazon Basin. J. Infect. Dis. 190:417-424.
32. Wang, P., C. S. Lee, R. Bayoumi, A. Djimde, O. Doumbo, G. Swedberg, L. D. Dao, H. Mshinda, M. Tanner, W. M. Watkins, P. F. Sims, and J. E. Hyde. 1997. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol. Biochem. Parasitol. 89:161-177.
33. Wang, X., J. Mu, G. Li, P. Chen, X. Guo, L. Fu, L. Chen, X. Su, and T. E. Wellems. 2005. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Am. J. Trop. Med. Hyg. 72:410-414.
34. Wootton, J. C., X. Feng, M. T. Ferdig, R. A. Cooper, J. Mu, D. I. Baruch, A. J. Magill, and X. Z. Su. 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418:320-323.
35. Zhou, Z., S. M. Griffing, A. M. de Oliveira, A. M. McCollum, W. M. Quezada, N. Arrospide, A. A. Escalante, and V. Udhayakumar. 2008. Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru. Antimicrob. Agents Chemother. 52:739-741.